本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

7.02
-0.3400-4.62%
盘后:7.020.00000.00%17:28 EDT
成交量:201.38万
成交额:1,425.88万
市值:6.12亿
市盈率:-3.30
高:7.36
开:7.30
低:6.99
收:7.36
52周最高:36.26
52周最低:6.65
股本:8,715.70万
流通股本:7,188.81万
量比:2.00
换手率:2.80%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
净资产收益率:-52.74%
总资产收益率:-31.82%
市净率:1.42
市盈率(LYR):-3.75

数据加载中...

2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/23

重要事件披露

8-K - Current report